key: cord-0751707-70q5h15j authors: Kataoka, Yuki; Oide, Shiho; Ariie, Takashi; Tsujimoto, Yasushi; Furukawa, Toshi A. title: COVID-19 randomized controlled trials in medRxiv and PubMed date: 2020-09-22 journal: Eur J Intern Med DOI: 10.1016/j.ejim.2020.09.019 sha: 1a1cfd6251bbc5e138e3151f3d65298cb476ab9c doc_id: 751707 cord_uid: 70q5h15j • This study investigated the difference between COVID-19 RCT in medRxiv and in PubMed. • SPIN in the conclusion was more frequently seen in reports in medRxiv than PubMed. • Readers should pay attention to the overstatements in preprints of COVID-19 RCT. PubMed. -SPIN in the conclusion was more frequently seen in reports in medRxiv than PubMed. -Readers should pay attention to the overstatements in preprints of COVID-19 RCT. Dear editor, Fast-track preprints have garnered increased attention since the COVID-19 pandemic. However, little is known about the quality of clinical research published as preprints. The objective of this study is to explore the differences in COVID-19 randomized controlled trial (RCT) articles between medRxiv and PubMed. This is a meta-epidemiological investigation. We published the protocol prior to conducting this study. 1 S1 Appendix is the reporting checklist. 2 We included RCT articles covering topics related to the COVID-19 practice indexed in PubMed or MedRxiv from 1st January 2020 to 15 th June. We searched abstracts that used the word "random" from medRxiv COVID-19 SARS-CoV-2 preprints. 3 We searched abstracts from PubMed using Shokraneh's filter for COVID-19 4 Cochrane filter for identifying randomized trials. 5 Two of three review authors (YK, SO, TA) selected abstracts from search results independently. Disagreements were resolved through discussion. One of three review authors (YK, SO, TA) selected full text articles and extracted data after calibration exercises. Disagreements were resolved through discussion. We evaluated the characteristics of included articles and the risk of bias using risk of bias tool 2 for the registered first primary outcome, or the outcome presented first in reports without the registration information. 6 We judged the presence of SPIN when there were positive expressions in the title or abstract conclusion in studies whose pre-registered primary outcome was non-significant. 7 We estimated the risk differences and confidence intervals for binary variables. We used Wilcoxon rank sum test for continuous variables. A p-value < .05 was considered statistically significant. Figure 1 shows the study selection procedure. We included a total of 29 RCT articles (13 from medRxiv, and 16 from PubMed). Table 1 shows the summary characteristics of the included articles. The citations of included articles and details of evaluations are shown in S2 Appendix. Three articles from PubMed did not show the trial registration numbers. Overall, more than 70% (21/29) articles were at high or some concerns for risk of bias, especially in the domain of selection of the reported results. There were 11 articles whose pre-registered primary outcomes both in medRxiv and peer-reviewed journal. One of them discussed limitations in the abstract in PubMed but not in medRxiv, apparently after peer-review. Our results suggest the existence of RCT articles that had problems with research methods and reporting in both medRxiv and PubMed journals related to the COVID-19 practice. In particular, the SPIN in the abstract conclusion was more frequently seen in reports in medRxiv. This study has several imitations, including small sample size, and not including preprint servers other than medRxiv. Further investigation on the impact of accelerated publication without peer review on the quality of reporting of clinical studies is warranted. Readers should pay attention to the overstatements in preprints of RCT. Because all data were retrieved from public databases, institutional review board approval is not required. Yuki Kataoka had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. .17 h Quality of COVID-19 research in preprints: a meta-epidemiological study protocol. protocols.io Guidelines for reporting meta-epidemiological methodology research Keeping up with studies on covid-19: systematic search strategies and resources RoB 2: a revised tool for assessing risk of bias in randomised trials Reporting and Interpretation of Randomized Controlled Trials With Statistically Nonsignificant Results for Primary Outcomes Guideline-based Chinese herbal medicine treatment plus standard care for severe coronavirus disease 2019 (G-CHAMPS): evidence from China. medRxiv Concept and design: All authors.